TRAF7 expression is upregulated in prostate cancer cells and mediates ubiquitin-mediated degradation of HOXA5, dysregulating the HOXA5-mediated reduction in cancer cell proliferation and invasion via P53 (John et al. 2022; Raman et al. 2000). Here, TP53 is linked to prostate carcinoma.